10:55 AM
 | 
Aug 08, 2018
 |  BC Extra  |  Politics & Policy

Louisiana seeks advice for subscription-based prescription plan

The Louisiana Department of Health has opened a public comment period on a proposed subscription-based HCV drug pilot program for patients on Medicaid or in the state's correctional facilities.

The program's goal is to create an incentive for the state to treat as many patients as possible, while drugmakers get a fixed purchase price and access to a broader patient population.

Under the existing payment model, treating 35,000 Medicaid-insured and uninsured patients infected with HCV would cost the state an estimated $764 million (see "Louisiana Pursues New Purchasing Model for HCV Drugs").

The Department of Health estimates that 30,000 patients on Medicaid or in correctional facilities carry the HCV virus, though only 384 patients were treated under Medicaid in 2017 due to the high price of medication.

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD